Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

被引：0
|
作者：
Xiao, Xiang [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Chengdu, Peoples R China
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.1760
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
1743
引用
收藏
页数：4
相关论文
共 50 条
  • [31] SGLT2 INHIBITORS IN IGA NEPHROPATHY: REAL-WORLD CLINICAL PRACTICE
    Garcia Carro, Clara
    Aiffil Meneses, Arianne
    Lopez Martinez, Marina
    Velo, Mercedes
    Rodriguez-Moreno, Antolina
    Soler Romeo, Maria Jose
    Sanchez Fructuoso, Ana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I397 - I398
  • [32] Generalisability of clinical trials of newer glucose-lowering drugs to real-world people with type 2 diabetes
    Butterly, E. W.
    Almazam, S. A.
    Alsallumi, K.
    McChrystal, R.
    Wei, L.
    McAllister, D. A.
    DIABETIC MEDICINE, 2023, 40
  • [33] DIABETIC COMPLICATIONS ASSOCIATED WITH SGLT2 AND DPP4 INHIBITORS: A REAL-WORLD APPROACH
    Kashambwa, R.
    Stapff, M.
    VALUE IN HEALTH, 2019, 22 : S141 - S141
  • [34] SGLT2 inhibitors and GLP1 agonists administered without metformin compared to other glucose-lowering drugs in patients with type 2 diabetes mellitus to prevent cardiovascular events: A systematic review
    Escobar, Carlos
    Barrios, Vivencio
    Cosin, Juan
    Gamez Martinez, Jose Maria
    Huelmos Rodrigo, Ana Isabel
    Ortiz Cortes, Carolina
    Torres Llergo, Javier
    Requeijo, Carolina
    Sola, Ivan
    Martinez Zapata, M. Jose
    DIABETIC MEDICINE, 2021, 38 (03)
  • [35] Glucose-Lowering Effect of SGLT2 Inhibitors Varies among Seasons in Japanese Subjects with Type 2 Diabetes
    Wada, Yoshiharu
    Hamamoto, Yoshiyuki
    Fujikawa, Jun
    Honjo, Sachiko
    Abe, Megumi
    Okamura, Emi
    Hamasaki, Akihiro
    DIABETES, 2017, 66 : A459 - A459
  • [36] SGLT2i Is Associated with Lower Risk of Mortality and Heart Failure Compared with Other Glucose-Lowering Drugs: A Three-Country Analysis
    Birkeland, Kre I.
    Jorgensen, Marit E.
    Carstensen, Bendix
    Gulseth, Hanne L.
    Thuresson, Marcus
    Fenici, Peter
    Bodegard, Johan
    Norhammar, Anna
    DIABETES, 2017, 66 : A322 - A322
  • [37] Renoprotective Effects of SGLT2 Inhibitors in Japanese Real-World Clinical Practice
    Tosaki, Takahiro
    Sato, Shiori Toga
    Kondo, Masaki
    Yamada, Yuichiro
    Inagaki, Akemi
    Tsunekawa, Shin
    Himeno, Tatsuhito
    Kato, Yoshiro
    Nakamura, Jiro
    Kamiya, Hideki
    DIABETES, 2019, 68
  • [38] Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study
    G. P. Fadini
    P. Li Volsi
    E. Devangelio
    M. Poli
    G. Cazzetta
    G. Felace
    A. Avogaro
    Journal of Endocrinological Investigation, 2020, 43 : 329 - 336
  • [39] Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study
    Fadini, G. P.
    Li Volsi, P.
    Devangelio, E.
    Poli, M.
    Cazzetta, G.
    Felace, G.
    Avogaro, A.
    Consoli, Agostino
    Formoso, Gloria
    Grossi, Giovanni
    Pucci, Achiropita
    Sesti, Giorgio
    Andreozzi, Francesco
    Capobianco, Giuseppe
    Gatti, Adriano
    Bonadonna, Riccardo
    Zavaroni, Ivana
    Dei Cas, Alessandra
    Felace, Giuseppe
    Li Volsi, Patrizia
    Buzzetti, Raffaella
    Leto, Gaetano
    Sorice, Gian Pio
    D'Angelo, Paola
    Morano, Susanna
    Bossi, Antonio Carlo
    Duratorre, Edoardo
    Franzetti, Ivano
    Morpurgo, Paola Silvia
    Orsi, Emanuela
    Querci, Fabrizio
    Boemi, Massimo
    D'Angelo, Federica
    Petrelli, Massimiliano
    Aimaretti, Gianluca
    Karamouzis, Ioannis
    Cavalot, Franco
    Saglietti, Giuseppe
    Cazzetta, Giuliana
    Cervone, Silvestre
    Devangelio, Eleonora
    Lamacchia, Olga
    Arena, Salvatore
    Di Benedetto, Antonino
    Frittitta, Lucia
    Giordano, Carla
    Piro, Salvatore
    Rizzo, Manfredi
    Chianetta, Roberta
    Mannina, Carlo
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2020, 43 (03) : 329 - 336
  • [40] The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study
    Agur, Timna
    Steinmetz, Tali
    Goldman, Shira
    Zingerman, Boris
    Bielopolski, Dana
    Nesher, Eviatar
    Fattal, Ittai
    Meisel, Eshcar
    Rozen-Zvi, Benaya
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
12345